# Screening for Silent Atrial Fibrillation During Influenza Vaccination

Study · id `cardio:ct-nct02006524` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02006524](<https://clinicaltrials.gov/study/NCT02006524>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02006524

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3269 participants.

## Technical summary

Registry record NCT02006524. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-10 (registry gives no type); primary completion 2014-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 3269 participants (enrolled count; ClinicalTrials.gov record NCT02006524, source copy `cardio:ctgov-nct02006524-2016-05-12`, retrieved 2026-10-26)
- Start date: 2013-10 (registry gives no type) (ClinicalTrials.gov record NCT02006524, source copy `cardio:ctgov-nct02006524-2016-05-12`, retrieved 2026-10-26)
- Primary completion: 2014-12 (actual) (ClinicalTrials.gov record NCT02006524, source copy `cardio:ctgov-nct02006524-2016-05-12`, retrieved 2026-10-26)
- Completion: 2014-12 (actual) (ClinicalTrials.gov record NCT02006524, source copy `cardio:ctgov-nct02006524-2016-05-12`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT02006524, source copy `cardio:ctgov-nct02006524-2016-05-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02006524-2016-05-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Screening for Silent Atrial Fibrillation During Influenza Vaccination
- Condition: Atrial Fibrillation
- Intervention (Device): 'MyDiagnostick
- Lead sponsor: UMC Utrecht
- Lead sponsor class: OTHER
- Collaborator: Boehringer Ingelheim
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: UMC Utrecht (`cardio:org-umc-utrecht`)
- Registry lists this organization as a collaborator: Boehringer Ingelheim (`cardio:boehringer-ingelheim`)

## Provenance

Content hash: f10cf04f0485af443813c6ea622bbfdb850fbef96673c46aeeef6bd466ad74c8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
